Mphasis Schedules Investor/Financial Analyst Day 2026 on May 27 in Mumbai

1 min read     Updated on 11 May 2026, 08:23 AM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Mphasis Limited has announced its Investor/Financial Analyst Day 2026, scheduled as a physical event on Wednesday, May 27, 2026, at 9:00 a.m. IST in Mumbai. The event is intended for institutional investors and financial analysts, and has been intimated to stock exchanges pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Presentations from the event will be submitted to stock exchanges prior to commencement and will be available on the company's official website. The schedule remains subject to change due to exigencies on the part of investors or the company.

powered bylight_fuzz_icon
40013595

*this image is generated using AI for illustrative purposes only.

Mphasis Limited has announced the scheduling of its Investor/Financial Analyst Day 2026, notifying the stock exchanges in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The event is designed to engage institutional investors and financial analysts, providing them with a structured forum to interact with the company's leadership.

Event Details

The Investor/Financial Analyst Day 2026 will be held as a physical event in Mumbai. The key details of the scheduled event are as follows:

Parameter: Details
Participants: Institutional Investors and Financial Analysts
Day & Date: Wednesday, May 27, 2026
Time: 9:00 a.m. IST
Type of Meeting: Physical
Location: Mumbai

Disclosures and Presentations

In accordance with regulatory requirements, Mphasis has stated that presentations to be made at the event will be submitted to the stock exchanges before the event commences. These presentations will also be hosted on the company's official website at www.mphasis.com . The intimation regarding the event is similarly available on the company's website.

It is noted that the above-mentioned schedule is subject to change due to exigencies on the part of investors or the company. The filing was signed by Mayank Verma, Senior Vice President and Company Secretary, Membership No.: ACS 18776, on behalf of Mphasis Limited.

Historical Stock Returns for Mphasis

1 Day5 Days1 Month6 Months1 Year5 Years
-1.10%-4.37%-8.40%-24.82%-14.82%+18.60%

What strategic growth targets or financial guidance is Mphasis likely to unveil at the Analyst Day 2026, particularly regarding AI-driven revenue streams?

How might Mphasis's presentations at the Analyst Day influence institutional investor sentiment and impact the stock's valuation multiples in the near term?

Will Mphasis use the Analyst Day platform to announce new client wins, partnerships, or expansion into emerging technology verticals like generative AI or cloud services?

Mphasis Allots Equity Shares Under ESOP 2016 and RSU Plan 2021 on 7 May 2026

1 min read     Updated on 08 May 2026, 06:23 AM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Mphasis Limited disclosed the allotment of equity shares under ESOP 2016 (37,750 shares) and RSU Plan 2021 (1,443 shares) following a resolution by the ESOP Compensation Committee on 7 May 2026. The Mphasis Employees Equity Reward Trust and Mphasis Employees Benefit Trust will deduct shares to cover exercise prices and applicable taxes, with sale proceeds used to repay company loans, as approved at respective Annual General Meetings.

powered bylight_fuzz_icon
39716644

*this image is generated using AI for illustrative purposes only.

Mphasis Limited has intimated the stock exchanges regarding the allotment of equity shares following the exercise of Employee Stock Options (ESOPs) and Restricted Stock Units (RSUs). The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The ESOP Compensation Committee, via a resolution passed on 7 May 2026, approved the allotment of these shares under the Employee Stock Options Plan 2016 (ESOP 2016) and Restricted Stock Units Plan 2021 (RSU Plan 2021).

Details of Allotment

The company provided a breakdown of the equity shares allotted under the specific plans. The allotment covers the exercise of options by employees as per the terms and time periods defined in the respective schemes, which have previously been submitted to the Stock Exchanges.

Plan: Equity Shares Allotted
ESOP 2016 37,750
RSU Plan 2021 1,443

Cashless Scheme and Tax Deductions

The company outlined specific procedures regarding the cashless scheme for employees who exercised ESOPs. Under Section 67 of the Companies Act, 2013, as approved by shareholders at the 33rd Annual General Meeting held on 25 July 2024, the Mphasis Employees Equity Reward Trust will deduct an appropriate number of shares from the allotted allotment. This deduction is intended to cover the exercise price funded and applicable taxes. The proceeds from the sale of these deducted shares will be utilized by the Trust to repay loans from the Company and pay applicable taxes.

Similarly, for the RSU Plan 2021, the Mphasis Employees Benefit Trust will deduct shares to cover the funded exercise price and applicable taxes upon vesting or exercise. This action is based on shareholder approval obtained under Section 67 of the Companies Act, 2013, at the 30th Annual General Meeting held on 29 September 2021. The proceeds from the sale of these shares will be used to repay company loans and taxes.

The intimation was signed by Mayank Verma, Senior Vice President and Company Secretary of Mphasis, on 7 May 2026. Further information is available on the company's official website at www.mphasis.com .

Historical Stock Returns for Mphasis

1 Day5 Days1 Month6 Months1 Year5 Years
-1.10%-4.37%-8.40%-24.82%-14.82%+18.60%

How might the continued dilution from ESOP and RSU allotments impact Mphasis' earnings per share trajectory over the next few fiscal years?

Could the frequency and scale of ESOP exercises signal growing employee confidence in Mphasis' stock outlook, and what does this imply for talent retention in a competitive IT services market?

How does Mphasis' cashless ESOP scheme structure compare to industry peers, and could regulatory changes under SEBI or the Companies Act affect such trust-based mechanisms in the future?

More News on Mphasis

1 Year Returns:-14.82%